Status
Ongoing
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.
Status
Ongoing
Classification
Class I
Report Date
September 6, 2023
Termination Date
—